Analysis of Neurodegenerative Process Within Visual Ways In Multiple Sclerosis
NCT03656055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2022-09-21
Summary
This study will interest in the pathophysiology of silent retinal axonal loss in multiple sclerosis. Recent studies have suggested that silent retinal axonal loss (no past history of optic neuritis \[ON\]) may be due to inflammatory lesions within the optic radiations and a transsynaptic degenerative process. The objective is to measure the exact role of silent optic nerve lesion in the occurrence of silent retinal axonal loss by performing OCT, brain and optic nerve MRI in a cohort of patients without recent disease activity.
Conditions
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Olivier Outteryck, MD, PhD · University Hospital, Lille
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-21
- Primary Completion
- 2018-01-03
- Completion
- 2019-01-03
Countries
- France
Study Locations
More Related Trials
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
NCT03356366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
VIsual Pathways Model in Neuro-inflammatory Disorders
NCT05487989 ·Status: RECRUITING
-
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
NCT03025269 ·Status: COMPLETED
-
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography
NCT04705610 ·Status: COMPLETED ·Phase: NA
-
Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study
NCT03659981 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
NCT06675955 ·Status: RECRUITING ·Phase: PHASE3
-
Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study
NCT03624296 ·Status: UNKNOWN ·Phase: NA
-
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
NCT04458688 ·Status: RECRUITING
-
Cerebrovascular Changes in Multiple Sclerosis Patients
NCT03709290 ·Status: UNKNOWN
-
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NCT05510817 ·Status: RECRUITING ·Phase: NA
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
NCT05177523 ·Status: RECRUITING
-
Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters
NCT03108573 ·Status: COMPLETED
-
Cortical Lesions in Patients With Multiple Sclerosis
NCT03653585 ·Status: COMPLETED
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
Multiple Sclerosis Prediction and Monitoring of Progression Study
NCT05685784 ·Status: RECRUITING ·Phase: NA
-
To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion
NCT02043964 ·Status: COMPLETED ·Phase: NA
-
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
NCT05633875 ·Status: RECRUITING
-
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
NCT02017808 ·Status: COMPLETED
-
Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
NCT03401307 ·Status: COMPLETED
-
Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis
NCT01272596 ·Status: COMPLETED
-
The Energetic Origin of Neurodegeneration in MS
NCT04532944 ·Status: UNKNOWN ·Phase: NA